Camping World's Q4 2024: Unpacking Contradictions in Inventory Strategy, Pricing, and SG&A

Generated by AI AgentAinvest Earnings Call Digest
Thursday, Feb 27, 2025 12:01 am ET1min read
CWH--
These are the key contradictions discussed in Camping World's latest 2024Q4 earnings call, specifically including: Inventory Strategy and Market Share Gains, Pricing and ASP Strategy, and SG&A Improvements:



Record Combined Market Share and Growth Strategy:
- Camping World Holdings reported record combined new and used market share of 11.2% for 2024.
- The company aims to achieve a new record of 12% market share in 2025, selling over 130,000 units.
- The growth strategy is driven by increased used inventory procurement and an emphasis on affordability and value-priced units.

Earnings Recovery and SG&A Reduction:
- Camping World expects explosive EBITDA growth in 2025, driven primarily by gross margin and SG&A improvements.
- The company targets a 600 to 700 basis point improvement in SG&A as a percentage of gross profit.
- This is due to strategic cost adjustments and a focus on operational efficiency.

Favorable Finance Rates and ASP Trends:
- The company notes a 50 to 100 basis points reduction in retail interest rates compared to a year ago.
- This is expected to accelerate retail finance rate relief and allow customers to take on more units with consistent monthly payments.
- The expected ASP for new and used units is $40,000 and $32,000, respectively, with a focus on affordability.

Acquisition and Dealer Expansion:
- Camping World plans to acquire 4-6 rooftops by the end of spring, adding to the 4 already closed in 2025.
- These acquisitions aim to expand market dominance and maintain used business dominance.
- The strategy is supported by a strong pipeline and focus on judicious capital allocation.

Discover what executives don't want to reveal in conference calls

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet